Caveat emptor – hidden pitfalls in defining the 99th percentile of cardiac troponin assays

Articles in the same Issue

1. Frontmatter
2. Editorial
3. High-sensitivity assay for cardiac troponins with POCT methods. The future is soon
4. Review
5. The assessment of circulating cell-free DNA as a diagnostic tool for breast cancer: an updated systematic review and meta-analysis of quantitative and qualitative ssays
6. Mini Review
7. Which laboratory technique is used for the blood sodium analysis in clinical research? A systematic review
8. Guidelines and Recommendations
9. IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals
10. General Clinical Chemistry and Laboratory Medicine
11. Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients
12. S100B protein, cerebral ultrasound and magnetic resonance imaging patterns in brain injured preterm infants
13. Urinary exosomal CD26 is associated with recovery from acute kidney injury in intensive care units: a prospective cohort study
14. Evaluation of red blood cell parameters provided by the UF-5000 urine auto-analyzer in patients with glomerulonephritis
15. Reference Values and Biological Variations
16. Pediatric reference interval verification for common biochemical assays on the Abbott Alinity system
17. Paediatric reference range for overnight urinary cortisol corrected for creatinine
18. Cancer Diagnostics
19. Circulating pro-gastrin releasing peptide (ProGRP) in patients with medullary thyroid carcinoma
20. Cardiovascular Diseases
21. Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay
22. Comparison of the analytical performance of the PATHFAST high sensitivity cardiac troponin I using fresh whole blood vs. fresh plasma samples
23. Infectious Diseases
24. Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series
25. Analytical validation of an automated assay for the measurement of adenosine deaminase (ADA) and its isoenzymes in saliva and a pilot evaluation of their changes in patients with SARS-CoV-2 infection
26. A new tool for sepsis screening in the Emergency Department
27. Letters to the Editor
28. Caveat emptor – hidden pitfalls in defining the 99th percentile of cardiac troponin assays
29. Assay requirements for COVID-19 testing: serology vs. rapid antigen tests
30. Stability of SARS-CoV-2 RNA in FTA card spot-prep samples derived from nasopharyngeal swabs
31. Homocysteine (Hcy) assessment to predict outcomes of hospitalized Covid-19 patients: a multicenter study on 313 Covid-19 patients
32. Concomitant immune thrombocytopenia and bone marrow hemophagocytosis in a patient with SARS-CoV-2
33. Procalcitonin measurement by Diazyme™ immunturbidimetric and Elecsys BRAHMS™ PCT assay on a Roche COBAS modular analyzer
34. Use of Neurosoft expert system improves turnaround time in a laboratory section specialized in protein diagnostics: a two-year experience
35. Impact of different sampling and storage procedures on stability of acid/base parameters in venous blood samples
36. Compound heterozygotes of Hb Constant Spring and Hb Stanleyville II in HbE/β⁰-thalassemia
37. Congress Abstracts
38. 60th National Congress of the Hungarian Society of Laboratory Medicine